Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IBRX
#815
ImmunityBio, Inc. Common Stock
9.7
8
+3.93%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+3.93%
Monthly Change
+63.00%
6 month change
+312.66%
Year Change
+213.46%
Previous Close
9.4
1
Open
9.7
8
Bid
Ask
Low
9.7
8
High
9.7
8
Volume
189
Markets
US Stock Market
Healthcare
IBRX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
ImmunityBio completes enrollment in bladder cancer trial
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Netflix and Palantir among market cap stock movers on Wednesday
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
AMD and Keysight Technologies among market cap stock movers on Tuesday
Tesla, Oracle among market cap stock movers on Monday
H.C. Wainwright raises Immunitybio stock price target to $15
ImmunityBio (IBRX) Reports Q4 Loss, Beats Revenue Estimates
American Express, Oracle among market cap stock movers on Monday
Immunitybio Inc earnings beat by $0.05, revenue topped estimates
ImmunityBio Shares Surge On 700% Revenue Growth Driven By Anktiva - ImmunityBio (NASDAQ:IBRX)